ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS AND IMMUNOFILTERING

摘要

The invention relates generally to compositions and methods for altering the isoelectric point of an antibody, and in some cases, resulting in improved plasma pharmacokinetics, e.g. increased serum half-life in vivo.